NM_002948.5:c.75C>G

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_002948.5(RPL15):​c.75C>G​(p.Val25Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00633 in 1,613,670 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V25V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0053 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0064 ( 44 hom. )

Consequence

RPL15
NM_002948.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.209

Publications

2 publications found
Variant links:
Genes affected
RPL15 (HGNC:10306): (ribosomal protein L15) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of four RNA species and approximately 80 structurally distinct proteins. This gene encodes a member of the L15E family of ribosomal proteins and a component of the 60S subunit. This gene shares sequence similarity with the yeast ribosomal protein YL10 gene. Elevated expression of this gene has been observed in esophageal tumors and gastric cancer tissues, and deletion of this gene has been observed in a Diamond-Blackfan anemia (DBA) patient. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Mar 2017]
NKIRAS1 (HGNC:17899): (NFKB inhibitor interacting Ras like 1) Predicted to enable GTPase activating protein binding activity. Predicted to be involved in I-kappaB kinase/NF-kappaB signaling. Predicted to act upstream of or within several processes, including Ral protein signal transduction; lung alveolus development; and surfactant homeostasis. Located in cytosol and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 3-23917934-C-G is Benign according to our data. Variant chr3-23917934-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 436551.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.209 with no splicing effect.
BS2
High AC in GnomAd4 at 812 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPL15NM_002948.5 linkc.75C>G p.Val25Val synonymous_variant Exon 2 of 4 ENST00000307839.10 NP_002939.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPL15ENST00000307839.10 linkc.75C>G p.Val25Val synonymous_variant Exon 2 of 4 1 NM_002948.5 ENSP00000309334.5

Frequencies

GnomAD3 genomes
AF:
0.00534
AC:
813
AN:
152218
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00818
Gnomad ASJ
AF:
0.0216
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00732
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00529
AC:
1320
AN:
249536
AF XY:
0.00531
show subpopulations
Gnomad AFR exome
AF:
0.000903
Gnomad AMR exome
AF:
0.00330
Gnomad ASJ exome
AF:
0.0227
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00162
Gnomad NFE exome
AF:
0.00728
Gnomad OTH exome
AF:
0.00740
GnomAD4 exome
AF:
0.00643
AC:
9397
AN:
1461334
Hom.:
44
Cov.:
31
AF XY:
0.00644
AC XY:
4681
AN XY:
726978
show subpopulations
African (AFR)
AF:
0.000867
AC:
29
AN:
33456
American (AMR)
AF:
0.00416
AC:
186
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.0204
AC:
534
AN:
26122
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00220
AC:
190
AN:
86226
European-Finnish (FIN)
AF:
0.00152
AC:
81
AN:
53390
Middle Eastern (MID)
AF:
0.0169
AC:
96
AN:
5682
European-Non Finnish (NFE)
AF:
0.00702
AC:
7807
AN:
1111696
Other (OTH)
AF:
0.00784
AC:
473
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
457
913
1370
1826
2283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00533
AC:
812
AN:
152336
Hom.:
3
Cov.:
33
AF XY:
0.00524
AC XY:
390
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00161
AC:
67
AN:
41576
American (AMR)
AF:
0.00817
AC:
125
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0216
AC:
75
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4824
European-Finnish (FIN)
AF:
0.00122
AC:
13
AN:
10620
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00732
AC:
498
AN:
68036
Other (OTH)
AF:
0.00851
AC:
18
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
46
91
137
182
228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00529
Hom.:
2
Bravo
AF:
0.00604
EpiCase
AF:
0.00976
EpiControl
AF:
0.00978

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RPL15: BP4, BP7, BS2 -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 02, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

RPL15-related disorder Benign:1
Aug 12, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Diamond-Blackfan anemia 12 Benign:1
Oct 30, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
14
DANN
Benign
0.85
PhyloP100
0.21
PromoterAI
0.051
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35629664; hg19: chr3-23959425; API